BIOGEN INC. (BIIB) Total liabilities 2016–2025
BIOGEN INC. (BIIB) total liabilities at each fiscal year-end, per SEC filings.
$11.2BFY2025 · since FY2016: $10.7B → $11.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.2B | -1.3% |
| FY2024 | $11.3B | -5.9% |
| FY2023 | $12.0B | +7.9% |
| FY2022 | $11.2B | -13.6% |
| FY2021 | $12.9B | -7.3% |
| FY2020 | $13.9B | +0.3% |
| FY2019 | $13.9B | +13.4% |
| FY2018 | $12.3B | +10.9% |
| FY2017 | $11.1B | +2.8% |
| FY2016 | $10.7B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice